Speaker


Kinga Matuła | CEO, QurieGen

Kinga Matuła is the CEO and co-founder of QurieGen. With over ten years of experience in research at the intersection of chemistry, biology, and physics, Kinga is passionate about turning scientific discoveries into tangible impacts. As a former oncological patient, she is deeply committed to bridging the gap between innovation and patients. Kinga has received startup business development training from various programs, including the Silicon Valley Draper Hero Program. Under her leadership, QurieGen won the Venture Challenge (May 2022) and received a Golden Ticket to Silicon Valley's prestigious 5-week accelerator program (July 2022), placing 2nd in Demo Day led by Tim Draper (selected out of 55 companies from 27 countries).   


QurieGen

QurieGen (est. 2022) is a biotech startup focused on developing innovative approaches for cancer treatment by understanding the underlying cellular mechanisms that drive diseases. QurieGen's platform combines a high-throughput proprietary method of mapping cellular responses, single-cell genomics, data science to build predictive models of disease biology and drug response. This discovery platform will enable to identify new drug targets, develop more effective therapies, and reduce the time and cost associated with traditional drug discovery and development. QurieGen is preparing to close a first investment to cement the trajectory toward the data-driven company.

Powered by:
Hyphen Projects   

Let's connect:           
Book a ticket
FAQ
Contact Us
Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
          
 
 

                                    

Keep me informed Download our event app


© Copyright 2023 by Hyphen Projects